U.S. awards contract to produce swabs for point-of-care test
The departments of Health and Human Services and Defense yesterday announced an $11.6 million contract to domestically produce more nasal swabs for the Cue Health molecular testing system, which detects the COVID-19 virus in about 20 minutes at the point of care.
The contract will allow Puritan Medical Products Company to expand domestic production capacity to 3 million per month by March 2021, the agencies said. HHS recently distributed 27,000 Cue Health test kits to Alaska, Florida, Louisiana, New Jersey and Texas for a pilot test. The Food and Drug Administration has authorized emergency use of the testing system in patient care settings operating under a CLIA certificate of waiver, compliance or accreditation.
Related News Articles
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…